It happens with regularity during citizen open-mike sessions at FDA drug advisory committee hearings. A queue of “patients” materializes out of nowhere to testify, often in tears, about the crucial need for a new drug or new use approval. Some are flown in by Pharma. Continue reading →
Is patient safety being compromised in the rush to approve new drugs?
There is a reason drug safety experts recommend waiting five years before taking a new prescription drug. Before new drugs are released to the public, they are tested on a shockingly small group of people for a shockingly short period of time. Risks and safety problems, therefore, often don’t emerge until millions try the drug as we saw with the withdrawn drugs Vioxx, Bextra, Baycol, Trovan, Meridia, Seldane, Hismanal, Darvon, Raxar, Redux and at least 11 others. Continue reading →
There can be a downside to a full head of orange hair
Last week, President Trump’s doctor disclosed that the president takes finasteride, a drug marketed as Propecia, to treat male pattern baldness. While it is tempting to make jokes about Trump’s hair, and even the sexual side effects that accompany the drug, it also has many disturbing side effects that neither the president—nor any other man—should risk. Continue reading →
Since 2005 when the USDA rolled out a new food pyramid that the meat industry said reduced red meat’s place in a healthy diet to a mere “condiment,” the USDA has continued to discredit red meat as a healthful food. Then, an advisory committee developing the 2015 Dietary Guidelines for American, which are revamped every five years, said Americans should eat less red and processed meat in favor of a “diet higher in plant-based foods,” further inflaming the meat industry. Committee members even played the environment card and wrote that a red meat-based diet “has a larger environmental impact in terms of increased greenhouse gas emissions, land use, water use, and energy use,” compared to plant-based and Mediterranean-style diets. Continue reading →
Since 2005 when the USDA rolled out a new food pyramid that the meat industry said reduced red meat’s place in a healthy diet to a mere “condiment,” the USDA has continued to discredit red meat as a healthful food. Then, an advisory committee developing the 2015 Dietary Guidelines for American, which are revamped every five years, said Americans should eat less red and processed meat in favor of a “diet higher in plant-based foods,” further inflaming the meat industry. Committee members even played the environment card and wrote that a red meat-based diet “has a larger environmental impact in terms of increased greenhouse gas emissions, land use, water use, and energy use,” compared to plant-based and Mediterranean-style diets. Continue reading →
It has been six years since the BBC, while reporting on a cloned cattle herd in Britain, said cloned products have been in the U.S. food supply for two years. Margaret Wittenberg, global vice-president of Whole Foods Market at the time agreed. Continue reading →
With Big Pharma, first they promote it, then they discover the risks.
Are you depressed? It may have less to do with your mood than your birth control pills, high blood pressure pills, antibiotics or even anti-hair-loss drug, according to new research. New risks have also emerged with popular gastroesophageal reflux disease medicines and even the top-selling painkiller, Tylenol. Continue reading →
FDA orders antibacterials removed from soaps
When antibacterial dish, body and laundry soaps emerged in the 2000s, they were supposed to get you “better than clean.” They were an example of the “new, improved,” “more cleaning power,” “new fresh scent,” claims that drive consumer product sales. Continue reading →
There's a method to the madness of Big Pharma's prioritizing profit over human life.
It has been two years since Gilead Sciences Inc. rolled out its $1,000-a-pill hepatitis C drug Sovaldi, priced at $84,000 for a course of treatment and met with disbelief from patients, insurers and health care professionals. After an 18-month investigation the Senate Finance Committee concluded prices did not reflect Gilead’s development costs and that the drug maker cared about “revenue” not “affordability and accessibility.” The committee also found that Sovaldi and a related pill, Harvoni, cost taxpayers $5 billion in 2014. Continue reading →
While SSRI antidepressants are arguably still the most consumed drug class in the US, sales peaked in 2008 and have declined by four percent every year since, according to Research and Markets. Continue reading →
You could even be ingesting it without your knowledge.
“I was given the antibiotic Levaquin. After 5 pills my body was burning and my right arm and legs were weak,” a reader posted after an article about underreported prescription drug dangers. “I discontinued the drug and was told I would be fine. 1 month later my feet started hurting, my knees developed chronic pain and I had stabbing pain in my quads. 13 months later, I have floaters in my vision, tinnitus, flat and deformed feet, rotator cuff damage, knee grinding, hip snapping, tendonitis and I can only walk for a few minutes.” Continue reading →
Look out for unbranded advertising and claims of a ‘silent epidemic.’
Did you ever wonder why new medications so often debut right after awareness of the condition they treat increases? It is no coincidence. The tactic is called unbranded advertising and “disease awareness,” and drug companies spend more on it than they do for regular advertising. Continue reading →
Girls with early onset puberty face a number of mental and physical health risks.
Padded bras for kindergarteners with growing breasts to make them more comfortable? Sixteen percent of U.S. girls experiencing breast development by the age of 7? Thirty percent by the age of 8? Clearly something is affecting the hormones of U.S. girls—a phenomenon also seen in other developed countries. Girls in poorer countries seem to be spared—until they move to developed countries. Continue reading →
Just as the public is digesting the fact that former chairman and CEO of drug giant Genentech, Art Levinson, is now the CEO of a new Google life sciences venture with Big Pharma and that he also serves as chairman of Apple Inc., there are more insidious “partnerships” between Pharma and top corporations. Walgreens has now announced a “partnership” with Mental Health America, an advocacy group so steeped in Pharma money, it was investigated by Congress. Continue reading →
Interview with Harry Haroutunian, MD, author of ‘Not as Prescribed—Recognizing and Facing Alcohol and Drug Misuse in Older Adults.’
Forgetfulness. Falls. Adding a new prescription or over-the-counter drug to address problems that are side effects of a previous drug. It is an increasingly common problem says a new book from Hazelden because people are taking more drugs than ever before and not always aware of their side effects and interactions. This “polypharmacy” can produce everything from falls and accidents to behavior that is quickly termed “dementia” in the elderly even when it is clearly from drug effects. The problem is compounded by doctors not always aware of what other doctors are prescribing a patient and the very addictive nature of many popular drugs today. Continue reading →
New Treasury Department rules helped scrap the alleged tax-dodging giant's attempt to merge with overseas firm.
Big Pharma received $127 billion of our tax dollars in 2014 through the federal programs Medicare, Medicaid, VA, and TRICARE. But just because they live on our tax dollars, doesn’t mean Pharma companies want to pay taxes. Increasingly, they seek tax inversions, reincorporating in countries like Britain, Ireland or the Netherlands, often merging with a European entity to duck U.S. taxes. Continue reading →
A few inconvenient truths you might need to know before tucking into that next bite of shrimp, beef or bacon.
From mercury in tuna and wood pulp in parmesan cheese to ground beef treated with ammonia to retard E. coli (“pink slime”), the press does a good job exposing the dangerous and deceptive practices of Big Food. The problem is, the public forgets about the food risk or contamination, assuming that reform is in the works and that is just fine with Big Food. Often nothing changes. Continue reading →
Pharma is creaming tens of billions out of the federal government in a variety of schemes
After an 18-month investigation into the high cost of Gilead’s hepatitis C drug Sovaldi—initially listed at $84,000 for a course of treatment or $1,000 per pill—the Senate Finance Committee said the prices did not reflect the cost of research and development and that Gilead cared about “revenue” not “affordability and accessibility.” That sounds like an understatement. Sovaldi and the related pill Harvoni cost Medicare and Medicaid more than $5 billion in 2014, charged senators. Continue reading →
What U.S. poultry producers do not want you to know about bird flu
A bird flu outbreak exposes the unethical and deceptive practices of poultry producers.
Posted on April 5, 2017 by Martha Rosenberg
Once again, bird flu is back in the U.S. From 2014 through mid-2015, 48 million chickens and turkeys were killed in the U.S. to prevent the disease’s spread and protect farmers’ profits. Continue reading →